Role of cytokines in the pathogenesis of acute pancreatitis

American Journal of Surgery

Volumn 175, Issue 1, 1998, Pages 76-83

  Norman, James ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACINAR CELL; ACUTE PANCREATITIS; APOPTOSIS; ARTICLE; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031984853     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00240-7     Document Type: Review

References (99)

1. 1. Leach SD, Gorelick FS, Modlin IM. New perspectives on acute pancreatitis. Scand J Gastroenterol. 1992;27(Suppl 192):29-38.
2. 2. Steinberg W, Tenner S. Acute pancreatitis. NEJM. 1994;330: 1198-1220.
3. 3. Jacobs ML, Daggett WM, Civetta JM, et al. Acute pancreatitis: analysis of factors influencing survival. Ann Surg. 1977;185:43-51.
4. 4. Banks P. Predictors of severity in acute pancreatitis. Pancreas. 1991;6:S7-12.
5. 5. Steer ML. How and where does acute pancreatitis begin? Arch Surg. 1992;127:1350-1353.
6. 6. Bettinger JR, Grendell JH. Intracellular events in the pathogenesis of acute pancreatitis. Pancreas. 1991;6:S2-6.
7. 7. Carey L. Extra-abdominal manifestations of acute pancreatitis. Surgery. 1979;86:337-342.
8. 8. Ranson JHC, Spencer FC. The role of peritoneal lavage in severe acute pancreatitis. Ann Surg. 1978;187:565-573.
9. 9. Stone HH, Fabian TC. Peritoneal dialysis in the treatment of acute alcoholic pancreatitis. Surg Gynecol Obstet. 1980;150:878-882.
10. 10. Mayer AD, McMahon MJ, Corfield AP, et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. NEJM. 1985;312:399-404.
11. 11. Denham W, Yang J, Fink G, Norman J. Pancreatic ascites as a powerful inducer of inflammatory cytokines: role of known versus unknown factors. Arch Surg. 1997;132:1231-1236.
12. 12. Seelig R, Eheman V, Tschahargane T, et al. The serum complement system - a mediator of acute pancreatitis. Virchows Arch (Path Anat). 1975;365:193-199.
13. 13. Whicher JT, Barnes MP, Brown A, et al. Complement activation and complement control proteins in acute pancreatitis. Gut. 1982;23:944-950.
14. 14. Galloway SW, Kingsnorth AN. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. Pancreas. 1996; 13:140-146.
15. 15. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochemical J. 1993;292:617-629.
16. 16. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg. 1995;82:1414-1420.
17. 17. Kingsnorth AN. Early treatment with lexipafant, a platelet activating factor antagonist reduces mortality in acute pancreatitis: a double blind, randomized, placebo controlled study. Gastroenterology. 1997;112:A453.
18. 18. Kikuchi Y, Shimosegawa T, Saroh A, et al. The role of nitric oxide in mouse cerulein-induced pancreatitis with and without lipopolysaccharide pretreatment. Pancreas. 1996;12:68-75.
19. 19. Werner J, Rivera J, Fernandez-del Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute endematous versus necrotizing pancreatitis. Surgery. 1997;121:23-30.
20. 20. Creagh TA, Leahy AL, Bouchier-Hayes DJ, et al. Oxygen free radicals and acute pancreatitis: fact or fiction? IJMS. 1993;162:497-498.
21. 21. Niederau C, Niederau M, Borchand F, et al. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Pancreas. 1992;7:486-496.
22. 22. Sandoval D, Gukovskaya A, Reavey P, et al. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology. 1996;111:1081-1091.
23. 23. Walsh CJ, Leeper-Woodford SK, Carey PD, et al. CD18 adhesion receptors, tumor necrosis factor, and neutropenia during septic lung injury. J Surg Research. 1991;50:323-329.
24. 24. di Giovine FS, Stones S, Duff GW. Cytokines: Identification and Measurement of Gene Activation. Tumour Immunobiology, a Practical Approach. New York: IRL Press; 1995:159-175.
25. 25. Dinarello CJ. The interleukin-1 family: 10 years of discovery. FASEB J. 1994;8:1314-1325.
26. 26. Aderem A. How cytokines signal messages within cells. J Infect Dis. 1993;167:S2-7.
27. 27. Dinarello C. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095-2147.
28. 28. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg. 1993;128:1235-1241.
29. 29. Whiteside TL. Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol. 1994;14:327-339.
30. 30. Leser HG, Gross V, Scheibenbogen, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101: 782-785.
31. 31. Exley AR, Leese T, Holliday MP, et al. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut. 1992;33:1126-1128.
32. 32. Viedma JA, Perez-Mateo M, Dominguez JE, et al. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut. 1992;33:1264-1267.
33. 33. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut. 1993;34:41-45.
34. 34. Galloway SW, Kingsnorth AN. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg. 1994;81: 312.
35. 35. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341-2348.
36. 36. Inagaki T, Hoshino M, Hayakawa T, et al. Interluekin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas. 1997;14:1-8.
37. 37. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 in the injured patients. Marker of injury or mediator of inflammation. Ann Surg. 1996;224:647-664.
38. 38. Kishimoto T, Akira S, Narazaki M, et al. Interleukin-6 family of cytokines and gp130. Blood. 1995;86:1243-1254.
39. 39. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmac. 1995;17:103-108.
40. 40. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest. 1992; 22:200-203.
41. 41. Dinarello CA, Gelfand JA, Wolff SM. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA. 1993;269:1829-1835.
42. 42. Montravers P, Chollet-Martin S, Marmuse JP, et al. Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Resp Crit Care Med. 1995;152:1527-1533.
43. 43. Wang J, Zao X, Yuan Z. The role of tumor necrosis factor in acute pancreatitis and associated multiple organ failure. Chung-Hua i Tsa Chih (Chinese Med J) 1995;75:133-135,188.
44. 44. Paajanen H, Laato M, Jaakkola M, et al. Serum tumour necrosis factor compared with c-reactive protein in the early assessment of severity acute pancreatitis. Br J Surg. 1995;82:271-273.
45. 45. Sameshima H, Ikei S, Mori K, et al. The role of tumor necrosis factor-alpha in the aggravation of cerulein-induced pancreatitis in rats. Int J Pancreatology. 1993;14:107-115.
46. 46. Fisher CJ, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randonized, open-lable, placebo controlled multicenter trial. Crit Care Med. 1994;22:12-21.
47. 47. de Beaux AC, Ross JA, Maingay JP, et al. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br J Surg. 1996;83:1071-1075.
48. 48. McKay CJ, Gallagher G, Brooks B, et al. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg. 1996;83:919-923.
49. 49. Simms HH, D'Amico R. Polymorphonuclear leukocyte dys-regulation during the systemic inflammatory response syndrome. Blood. 1994;83:1398-1407.
50. 50. Widdison, AL, Cunningham S. Immune function early in acute pancreatitis. Br J Surg. 1996;83:633-636.
51. 51. Mancini R, Incorvaia L, Miglioli M. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion. 1994;55:268-273.
52. 52. Norman J, Franz M, Riker A, et al. Rapid elevation of pro-inflammatory cytokines during acute pancreatitis and their origination within the pancreas. Surg Forum. 1994:148-160.
53. 53. Norman J, Fink G, Franz M. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg. 1995;130:966-970.
54. 54. Fink G, Norman J. Intrapancreatic interleukin-1beta gene expression by specific leukocyte populations during acute pancreatitis. J Surg Res. 1996;63:369-373.
55. 55. Fink G, Norman J. Specific changes in the pancreatic expression of the interleukin-1 family of genes during experimental acute pancreatitis. Cytokine. 1997, In Press.
56. 56. Blinman TA, Gukovsky IY, Gukovskaya S, et al. Pancreatic acinar cells express a variety of cytokines that are regulated in experimental pancreatitis. Gastroenterology. 1997;112:A429.
57. 57. Grewal HP, Kotb M, Mohy El Din A, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery. 1994;115:213-221.
58. 58. Fink G, Norman J. Pancreatitis induces specific changes in the intrapancreatic expression of the TNF family of genes. Pancreas. 1995;11:428A.
59. 59. de Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg. 1996;83:349-353.
60. 60. Norman J, Fink G, Denham W, et al. Tissue specific cytokine production during experimental acute pancreatitis: a problem mechanism for distant organ dysfunction. Dig Dis Sci. 1997;42: 1783-1788.
61. 61. Hughes CB, Henry J, Kotb M, et al. Up-regulation of TNF alpha mRNA in the rat spleen following induction of acute pancreatitis. J Surg Res. 1995;59:687-693.
62. 62. Parsons PE, Moore FA Moore EE, et al. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Resp Dis. 1992;146:694-700.
63. 63. Strieter RM, Kunkel Sl, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med. 1993;21:447-463.
64. 64. Denham W, Yang J, Fink G, Norman J. TNF but not IL-1 decreases acinar cell survival without affecting function: A study in the perfused human pancreas. J Surg Res. 1998;74:In Press.
65. 65. Fink G, Yang J, Norman J. Acute pancreatitis induced enzyme release and necrosis are attenuated by IL-1 antagonism though an indirect mechanism. J Surg Res. 1997;67:94-97.
66. 66. Dusetti NJ, Mallo GV, Ortiz EM, et al. Induction of lithostathine/reg mRNA expression by serum from rats with acute-pancreatitis and cytokes in pancreatic acinar AR-42J cells. Arch Biochem Biophys. 1996;330:129-132.
67. 67. Dusetti NJ, Ortiz EM, Mallo GV, et al. Pancreatitis-associated protein I (PAP I), an acute phase protein induced by cytokines. Identification of two functional interleukin-6 response elements in the rat PAP I promoter region. J Biol Chem. 1995;270:22417-22421.
68. 68. Viguerie N, Bertrand V, Dufresne M, et al. Interleukin-6 regulation of CCK/gastrin receptros and amylase secretion in a rat pancreatic acinar cell line. Eur Cytokine Network. 1994;5:433-440.
69. 69. Sutton ET, Norman J, Newton CA, et al. Endothelial structural integrity is maintained during endotoxic shock in a type-1 IL-1 receptor knockout mouse. Shock. 1997;7:104-110.
70. 70. Norman JG, Fink GW, Sexton C, et al. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1beta gene expression at steady-state and during the systemic stress induced by the acute pancreatitis. J Surg Res. 1996;63:231-236.
71. 71. Norman JG, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg. 1996;223:163-169.
72. 72. Denham W, Fink G, Norman J. Transgenic animals demonstrate modest additive detrimental effects of IL-1 and TNF during acute pancreatitis. Gastroenterology. 1997;113:1741-1746.
73. 73. Nagata S. Apoptosis by death factor. Cell. 1997;69:355-365.
74. 74. Kaiser AM, Saluja AK, Lu L, et al. Effects of cycloheximide on pancreatic endonuclease activity, apoptosis, and severity of acute pancreatitis. Am J Physiol (Cell Physiol 40). 1996;271:C982-C993.
75. 75. Gukovskaya AS, Perkins P, Zaninovic V, et al. Mechanism of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroentereology. 1996;110:876-884.
76. 76. Gukoyskaya AS, Sandoval D, Zaninovich V, et al. Tumor necrosis factor regulates cell death in caerulein-induced pancreatitis. Gastroenterology. 1996;111:A2791.
77. 77. Norman J, Denham W, Chapman V, et al. TNF induces acinar cell apoptosis during acute pancreatitis. Gastroenterology. 1997;112: A468.
78. 78. Kaiser AM, Saluja AK, Sengupta A, et al. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol. 1995;269:C1295-C1304.
79. 79. Guice K, Oldham KT, Remick DG, et al. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. J Surg Res. 1991;51:495-499.
80. 80. Hughes CB, Gaber LW, Kotb M, et al. Induction of acute pancreatitis in germ-free rats: evidence of a primary role for tumor necrosis factor-alpha. Surgery. 1995;117:201-205.
81. 81. Grewal HP, Mohey el Din A, Gaber L, et al. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-a polyclonal antibody. Am J Surg. 1994;167:214-219.
82. 82. Hughes CB, Gaber LW, Mohey el-Din AB, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg. 1996;62:8-13.
83. 83. Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 1996;171:274-280.
84. 84. Hughes CB, El-Din ABM, Kotb M, et al. Calcium channel blockade inhibits release of TNFa and improves survival in a rat model of acute pancreatitis. Pancreas. 1996;13:22-28.
85. 85. Norman J, Franz M, Fink G. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery. 1996;120:515-521.
86. 86. Windsor ACJ, Mullen PG, Walsh CJ, et al. Delayed tumor necrosis factor a blockade attenuates pulmonary dysfunction and metabolic acidosis associated with experimental gram-negative sepsis. Arch Surg. 1994;129:80-89.
87. 87. Tanaka N, Murata A, Uda K, et al. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit Care Med. 1995;23:901-908.
88. 88. Norman JG, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995;117:648-655.
89. 89. Norman JG, Franz MG, Fink GS, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg. 1995;221:625-631.
90. 90. Fink G, Yang J, Tracey KJ, Norman J. A low molecular weight macrophage inhibitor decreases severity of pancreatitis through inhibition of IL-1 and TNF production. Surg. Forum. 1996;47:137-140.
91. 91. Denham W, Fink G, Yang J, Norman J. Small molecule inhibition of TNF gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity. Am Surg. 1997;63:1045-1050.
92. 92. Yang J, Denham W, Tracey KJ, Norman J. The hemodynamic consequences of macrophage pacification during severe acute pancreatitis. Am J Phys. 1997. In Press.
93. 93. Norman J, Yang J, Fink G, et al. Severity and mortality of experimental pancreatitis are dependent upon interleukin-1 converting enzyme (ICE). J Interfer Cytokine Res. 1997;17:113-118.
94. 94. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995;108:1917-1922.
95. 95. Kusske AM, Rongione AJ, Ashley SW, et al. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery. 1996;120:284-288.
96. 96. Rongione AJ, Kusske AM, Kwan K, et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 1997;112:960-967.
97. 97. Rongione AJ, Kusske AM, Reber HA, et al. Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis. J Gastrointest Surg. 1997;1:159-166.
98. 98. Denham W, Yang J, Carter G, Norman J. Cationic liposome-mediated gene transfer during acute pancreatitis: tissue specificity, duration, and effects of acute inflammation. J Gastrointest Surg. 1998;2:95-101.
99. 99. Norman J, Denham W, Yang J, et al. Intrapancreatic transfection of human IL-10 gene decreases severity of acute pancreatitis. Gastroenterology. 1997;112:A467.